Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

ORIC Pharmaceuticals, Inc. ORIC

Set alert

Price alert · ORIC

All alert types
9.07 USD -0.17 -1.84%

At close

9.15 +0.08 +0.88%

Pre-market · Nov 3, 5:28 AM ET

Bid
9.05 × 1
Ask
9.07 × 2
9.00 Day range 9.37
7.23 52-week range 14.68
YTD
+10.88%
1 year
-28.53%
Open
9.29
Prev close
9.24
Mkt cap
940.13M
Vol
1.92M
Avg vol
1.58M
EPS
-1.32
P/E
0.00
Div yield
0.00%
More statistics
Low
9.00
High
9.37
Forward P/E
-7.87
Beta
0.98
Short ratio
11.16
Inst. own
123.41%
Dividend
0.00
Ex-div date
Earnings
Nov 12, 2026
50-d avg
12.96
200-d avg
11.13
1y target
21.64

5D chart

Chart tools
Interval
1m5m15m30m

Signals (130)
NameTimeAgo
SMA: BearishOct 30, 3:10 PM3 days ago
SMA: BearishOct 30, 2:45 PM3 days ago
MACD: Sell SignalOct 30, 2:35 PM3 days ago
MACD: Buy SignalOct 30, 2:20 PM3 days ago
SMA: BullishOct 30, 2:15 PM3 days ago
SMA: BearishOct 30, 2:00 PM3 days ago
MACD: Sell SignalOct 30, 2:00 PM3 days ago
RSI: OverboughtOct 30, 1:50 PM3 days ago
MACD: Buy SignalOct 30, 1:40 PM3 days ago
RSI: OverboughtOct 30, 1:40 PM3 days ago
MACD: Sell SignalOct 30, 1:35 PM3 days ago
MACD: Buy SignalOct 30, 12:45 PM3 days ago
SMA: BullishOct 30, 12:40 PM3 days ago
SMA: BearishOct 30, 12:35 PM3 days ago
MACD: Sell SignalOct 30, 12:35 PM3 days ago
SMA: BullishOct 30, 12:05 PM3 days ago
SMA: BearishOct 30, 12:00 PM3 days ago
SMA: BullishOct 30, 11:30 AM3 days ago
SMA: BearishOct 30, 11:25 AM3 days ago
SMA: BullishOct 30, 10:40 AM3 days ago

Newest 20 of 130.

Financial health

Altman Z-Score

21.20 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -5.6×
FY 2017: -1.6×FY 2018: -2.1×FY 2019: -18.4×FY 2020: -10.1×FY 2021: -7.1×FY 2022: -2.6×FY 2023: -4.7×FY 2024: -4.4×FY 2025: -5.6×
FY 2017 5y median -4.7× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 1.9×
FY 2017: 1.4×FY 2018: -0.7×FY 2019: 0.6×FY 2020: 2.6×FY 2021: 2.0×FY 2022: 1.1×FY 2023: 2.1×FY 2024: 2.3×FY 2025: 1.9×
FY 2017 5y median 2.0× FY 2025
P/FCF -6.3×
FY 2017: -1.7×FY 2018: -2.1×FY 2019: -2.0×FY 2020: -16.2×FY 2021: -9.2×FY 2022: -3.0×FY 2023: -5.5×FY 2024: -4.9×FY 2025: -6.3×
FY 2017 5y median -5.5× FY 2025
EV/EBITDA -5.3×
FY 2017: -0.5×FY 2018: -0.1×FY 2019: 1.6×FY 2020: -13.7×FY 2021: -4.3×FY 2022: -2.1×FY 2023: -4.6×FY 2024: -4.0×FY 2025: -5.3×
FY 2017 5y median -4.3× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -15.9%
FY 2017: -58.7%FY 2018: -47.5%FY 2019: -49.7%FY 2020: -6.2%FY 2021: -10.8%FY 2022: -33.1%FY 2023: -18.3%FY 2024: -20.2%FY 2025: -15.9%
FY 2017 5y median -18.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -33.7%
FY 2017: -85.6%FY 2018: 33.2%FY 2019: -30.6%FY 2020: -25.4%FY 2021: -28.8%FY 2022: -40.1%FY 2023: -44.9%FY 2024: -52.6%FY 2025: -33.7%
FY 2017 5y median -40.1% FY 2025
ROIC -36.3%
FY 2017: -82.2%FY 2018: -50.7%FY 2019: -32.2%FY 2020: -25.6%FY 2021: -27.6%FY 2022: -38.6%FY 2023: -46.7%FY 2024: -56.6%FY 2025: -36.3%
FY 2017 5y median -38.6% FY 2025
ROA -31.5%
FY 2017: -73.4%FY 2018: -45.7%FY 2019: -28.6%FY 2020: -24.7%FY 2021: -26.4%FY 2022: -35.6%FY 2023: -39.5%FY 2024: -46.6%FY 2025: -31.5%
FY 2017 5y median -35.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -0.1%
FY 2017: 0.0%FY 2018: 0.8%FY 2019: -27.7%FY 2020: -159.7%FY 2021: -6.3%FY 2022: -16.4%FY 2023: -20.7%FY 2024: -29.0%FY 2025: -0.1%
FY 2017 FY 2025
EPS (diluted) 19.7%
FY 2017: 0.0%FY 2018: 21.1%FY 2019: 88.6%FY 2020: -140.0%FY 2021: 38.4%FY 2022: -8.7%FY 2023: 12.9%FY 2024: 6.6%FY 2025: 19.7%
FY 2017 FY 2025
Free Cash Flow -0.2%
FY 2017: 0.0%FY 2018: 0.5%FY 2019: -14.6%FY 2020: -89.0%FY 2021: -31.7%FY 2022: -27.7%FY 2023: -12.1%FY 2024: -31.6%FY 2025: -0.2%
FY 2017 FY 2025

Financial Health

Current Ratio 14.1×
FY 2017: 10.2×FY 2018: 16.8×FY 2019: 16.8×FY 2020: 33.0×FY 2021: 15.9×FY 2022: 13.7×FY 2023: 10.4×FY 2024: 10.6×FY 2025: 14.1×
FY 2017 5y median 13.7× FY 2025
Quick Ratio 14.1×
FY 2017: 10.2×FY 2018: 16.8×FY 2019: 16.8×FY 2020: 33.0×FY 2021: 15.9×FY 2022: 13.7×FY 2023: 10.4×FY 2024: 10.6×FY 2025: 14.1×
FY 2017 5y median 13.7× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017: 1.2×FY 2018: 2.0×FY 2019: 3.4×FY 2020: 1.6×FY 2021: 2.9×FY 2022: 0.6×FY 2023: 0.1×FY 2024: 0.4×FY 2025: 0.3×
FY 2017 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -34.7×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31